Sanger sequencing confirmed breakpoint junctions in the genomic DNA, leading us to designate the KAT6B::ADK fusion genes found in the FUSCC-LU175 and FUSCC-LU260 breast cancer samples as KAT6B::ADK(175) and KAT6B::ADK(260), respectively. This evidence concerns the gene ADK and breast carcinoma.